1105 Tony Hunter: Time To Capitalize On Marketplace Opportunities

Automatic TRANSCRIPT

So what does all that stuff mean? So it means that our guest today he knows what he's talking about. He's not just a guy that talks the talk. He walks the walk as well. Welcome Tony to the Nice guys on business podcast pleasure to be hurt Doug. Thanks. For having me at love having you here man and and you know we talked a little bit in our pre interview just about some of this stuff and some of your your experience that you've been through and I love it because you've gone from publishing to pot from media to marijuana and conservative to cannabis. So can we start just a little bit with your back backstory 'cause I think it's so fascinating how you've gone from a really ultra conservative environment and publishing, and you're now into an entirely disruptive in a brand new world. So maybe share a little bit of your background and then we can take it from there. Tony. All thanks Doug I usually get asked that question that's not a straight line of course for most to think about a after a long career at Tribune company one of the greatest media companies in the world. After I left the company. There were three things I was looking for one in publishing mission. Our mission was always sold for and I wanted to have that I also love being an disruptive environment and the challenge and then third I enjoy. Building something and building a team and setting visions what I look at opportunities. On the mission side, you know cannabis a started out. In every state and I've had experience with friends and relatives that have seen the relief and benefits but disloyal cannabis and I really been attracted to that and natural medicine in general for about fifteen years now. So I started learning more about that and saw the impact it was having and I really believe that as regulations are relaxed, we're gonNA find more benefits of medicinal cannabis and so that intrigued me second clearly this is a disruptive You, know as this gains more traction more clinical trials, this will be disruptive form of treatment

Coming up next